Statins in stroke prevention: What an internist should know

European Journal of Internal Medicine

Volumn 19, Issue 1, 2008, Pages 8-14

  Castilla Guerra, Luis ^a   del Carmen Fernández Moreno, María ^b   López Chozas, José Manuel ^c   Jiménez Hernández, María Dolores ^a  

^a la Merced Osuna Seville Spain ^*  (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Lipids; Pleiotropic effects; Statins; Stroke prevention

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN;

CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG MECHANISM; HUMAN; MEDICAL SPECIALIST; REVIEW; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; PRACTICE GUIDELINES AS TOPIC; STROKE;

EID: 38149040013     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.05.010     Document Type: Review

References (39)

1. Endo A., Kuroda M., and Tsujita Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo) 29 (1976) 1346-1348
2. Sacco R.L., Adams R., Alberts G., et al. Guidelines for stroke prevention of stroke in patients with ischaemic stroke or transient isquemic attack. Stroke 37 (2006) 577-617
3. Castilla-Guerra L., Espino-Montoro A., Fernández-Moreno M.C., López-Chozas J.M., and Jimernez M.D. Statins and stroke. Current clinical practice. Stroke 37 (2006) 1153
4. Ovbiagele B., Saver J.L., Bang H., et al. Statins treatment and adherence to national colesterol guidelines after ischaemic stroke. Neurology 66 (2006) 1164-1170
5. Prospective Studies Collaboration: Cholesterol, diastolic blood pressure, and stroke: 13.000 strokes in 450.000 people in 45 prospective cohorts. Lancet 346 (1995) 1647-1653
6. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
7. Byington R.P., Davis B.R., Plehn J.F., et al. for the PPP Investigators. The Prospective Pravastatin Pooling (PPP) Project. Circulation 103 (2001) 387-392
8. Waters D.D., Schwartz G.G., Olsson A.G., et al. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation 106 (2002) 1690-1695
9. Athyros V.G., Papageorgiou A.A., Mercouris B.R., et al. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 18 (2002) 220-228
10. Shepherd J., Blauw G.J., Murphy M.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
11. Amarenco P., Labreuche J., Lavallée P.H., and Touboul P.J. Statins in stroke prevention and carotid atherosclerosis. Stroke 35 (2004) 2902-2909
12. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals. A randomised placebo-control trial. Lancet 360 (2002) 7-22
13. Ovbiagele B., Kidwell Ch S., and Saver J.L. Expanding indications for statins in cerebral ischemia. Arch Neurol 62 (2005) 67-72
14. Amarenco P., Bogousslavsky J., Callahan A., Goldstein L.B., Hennerici H., Rudolf A.E., et al. High-dose atorvastatin after stroke or transient ischaemic attack. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. N Engl J Med 355 (2006) 549-559
15. Hankey G.J. Statins after transient ischaemic attack and ischaemic stroke. Lancet Neurol 5 (2006) 810-812
16. Kent D.M. Stroke-an equal opportunity for the initiation of statin therapy. N Engl J Med 355 (2006) 613-615
17. Cohen J.S., East J.E., Elkind M.S.V., Khan N.A., Mascitelli L., Pezzetta F., et al. Statin therapy after stroke or transient ischaemic attack. N Engl J Med 355 (2006) 2368-2371
18. Rutishauser J. The role of statins in clinical medicine. LDL-cholesterol lowering and beyond. Swiss Med Wkly 136 (2005) 41-49
19. Crisby M., Nordin-Fredickssn G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques. Circulation 103 (2001) 926-933
20. Endres M., Laufs U., Huang Z., et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 95 (1998) 8880-8885
21. Casani L., Sanchez-Gómez S., Vilahur G., and Badimon L. Pravastatin reduces thrombogenicity by mechanisms beyond plasma cholesterol lowering. Thomb Haemost 94 (2005) 1035-1041
22. Stepien K., Tomaszewski M., and Czuczwar S.J. Neuroprotective properties of statins. Pharmacol Rep 57 (2005) 561-956
23. Becker K., and Chopp M. Role of statins in the treatment and prevention of stroke. Stroke 35 suppl 1 (2004) 2706-2707
24. Amarenco P., Lavallée P., and Touboul P.J. Statins and stroke prevention. Cerebrovasc Dis 17 suppl 1 (2004) 81-88
25. Vivancos-Mora J., and Gil-Núñez A.C. Lipids and stroke: the opportunity of lipid-lowering treatment. Cerebrovasc Dis 20 suppl 2 (2005) 53-67
26. Cook N.R., Cohen J., Hekbert P.R., Taylor J.O., and Henneckens C.H. Implications for small reduction in diastolic blood pressure for primary prevention. Arch Intern Med 155 (1995) 701-709
27. National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
28. Grundy S.M., Cleeman J.I., Merz C.N.B., Brewer H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110 (2004) 227-239
29. Sacco R.L., Adams R., Alberts G., Alberts M.J., Benavente O., Furie K., et al. Guidelines for stroke prevention of stroke in patients with ischaemic stroke or transient isquemic attack. Stroke 37 (2006) 577-617
30. Goldstein L.B., Adams R., Alberts M.J., Appel L.J., Brass L.M., Bushnell C.h.D., et al. Primary prevention of ischaemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 37 (2006) 1583-1633
31. Ross A.M., and Ganitas T.G. Results of new statins trials: should the low-density lipprotein cholesterol treatment guidelines be revised?. Curr Atheroscler Rep 7 (2005) 11-16
32. Dhamoon M.S., Sciacca R.R., Rundek T., Sacco R.L., and Elkind M.S.V. Recurrent stroke and cardiac risks after first ischaemic stroke. The Northern Manhattan Study. Neurology 66 (2006) 641-646
33. Amarenco P., and Tonkin A.M. Statins for stroke prevention. Disappointment and hope. Circulation 109 SupplIII (2004) 44-49
34. Chen J., Zhang Z.G., Li Y., et al. Statins can induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53 (2003) 743-751
35. Martí-Fabregas J., Gomis M., Arboix A., et al. Favorable outcome of ischaemic stroke in patients pretreated with statins. Stroke 35 (2004) 1117-1123
36. Kennedy J., Quan H., Buchan A.M., Ghali W.A., and Feasby T.E. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 36 (2005) 2072-2076
37. Sanossian N., Saver J.L., Liebeskind D.S., Kim D., Razinia T., and Ovbiagale B. Achieving target cholesterol goals after stroke: is in-hospital statin initiation the key?. Arch Neurol 63 (2006) 1081-1083
38. Yano K., Reed D.M., and McLean C.J. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 20 (1989) 1460-1465
39. Ebrahim S., Sung J., Song Y.M., Ferrer R.L., Lwalor D.A., and Davey-Smith G. Serum cholesterol, hemorrhagic stroke and myocardial infarction: Korean national heath system prospective cohort study. BMJ 333 (2006) 22-27